Kelly McCall, PhD

Education:

• Molecular & Cellular Biology (PhD), Ohio University, 2003
• Biological Sciences (BS), Ohio University, 1997

Expertise:

• Toll-like receptors
• Diabetes mellitus, Type 1 and 2
• Chronic inflammation
• Phenylmethimazole (C10)
• Cancer
• Atherosclerosis
• Wnt5a
• Novel therapeutics
• Nonalcoholic fatty liver disease
• Interferon regulatory factor-3
• Autoimmunity
• Autoimmune diseases
• Chronic inflammatory diseases
• Obesity
• Mouse models of disease

Summary of Work:     

I study molecular pathways involved in autoimmune/inflammatory diseases (AIDs) & utilize this knowledge to develop novel therapeutics. My work established aberrant toll-like receptor (TLR) expression & signaling in non-immune cells is a key mediator of AIDs; work that initiated a paradigm shift.

Links:

View My Work in ResearchGate 

View My Work in the National Center for Biotechnology Information (NCBI)